MS trades against a final fair-value range of $89.88-$161.78, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $89.9, high $162, with mid-point at $128.
Stock analysis
Morgan StanleyMS Morgan Stanley fair value $128–$162
Bu rapor henüz çevrilmedi. Çeviri kuyruğu yetiştiğinde birkaç dakika sonra sayfayı yenileyin.
§1 Yönetici özeti
Composite fair value $128 with high case $162.
Implied downside of 33.7% to fair value.
Moat 9/10 · confidence 88/100 · Financial.
Currently screens above fair value, so patience matters more than entry speed.
Fair value
$128
Margin of safety
-50.8%
Confidence
88/100
Moat
9/10
Educational analysis only — not financial advice. Always do your own due diligence.
$193.09Price
FV $128.06
High $161.78
MS trades against a final fair-value range of $89.88-$161.78, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Scale and brand prestige in
Scale and brand prestige in Wealth Management ($5T+ client assets).
Top-three global ranking in Equities
Top-three global ranking in Equities and Investment Banking.
Cycle upside
Expanding global money supply, robust IPO/M&A activity, and rising equity markets driving AUM growth.
Based on our latest analysis, MS looks meaningfully overvalued. The current price is $193 versus a composite fair-value midpoint of $128 (range $89.9–$162), which implies roughly 33.7% downside to the midpoint.
Our composite fair-value range for MS is $89.9–$162, with a midpoint of $128. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for Morgan Stanley's archetype.
Our current rating for MS is Sell with a confidence score of 88/100. MS is rated Sell at $193.09 versus the reconciled fair value midpoint of $128.06, implying -33.68% upside/downside. Confidence is separately disclosed at 88/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for Morgan Stanley are: Severe Equity Market Drawdown; Wealth Management Margin Compression; Regulatory Capital Penalties. The single biggest risk is Severe Equity Market Drawdown: A prolonged 20%+ market correction drives severe AUM attrition, compressing fee yields and crushing capital markets activity simultaneously.
Our current rating for MS is Sell, issued with a confidence score of 88/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($89.9–$162) versus the current price of $193.
Morgan Stanley is classified as a financial stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for MS.
